Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14 » default

Neuropsychiatric Disease and Treatment


Archive: Volume 14, 2018

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia

Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W

Neuropsychiatric Disease and Treatment 2018, 14:3373-3379

Published Date: 13 December 2018

Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides

Malo-Urriés M, Hidalgo-García C, Estébanez-de-Miguel E, Tricás-Moreno JM, Santos-Lasaosa S, Jahanshahi M

Neuropsychiatric Disease and Treatment 2018, 14:3363-3371

Published Date: 10 December 2018

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder

Huang YC, Shi X, Li ZY, Shen Y, Shi XX, Wang LY, Li GF, Yuan Y, Wang JX, Zhang YC, Zhao L, Zhang M, Kang Y, Liang Y

Neuropsychiatric Disease and Treatment 2018, 14:3329-3337

Published Date: 3 December 2018

Altered functional connectivity of primary visual cortex in late blindness

Wen Z, Zhou FQ, Huang X, Dan HD, Xie BJ, Shen Y

Neuropsychiatric Disease and Treatment 2018, 14:3317-3327

Published Date: 3 December 2018

Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics

Zheng W, Luo XN, Li HY, Ke XY, Dai Q, Zhang CJ, Zhang XY, Ning YP

Neuropsychiatric Disease and Treatment 2018, 14:3307-3315

Published Date: 30 November 2018

Effects of personality on the association between paroxetine plasma concentration and response

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K

Neuropsychiatric Disease and Treatment 2018, 14:3299-3306

Published Date: 29 November 2018

Developmental lead (Pb)-induced deficits in hippocampal protein translation at the synapses are ameliorated by ascorbate supplementation

Ahmad F, Salahuddin M, Alsamman K, AlMulla AA, Salama KF

Neuropsychiatric Disease and Treatment 2018, 14:3289-3298

Published Date: 29 November 2018

Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms

Uchida Y, Takahashi T, Katayama S, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2018, 14:3279-3287

Published Date: 27 November 2018

Children screening positive for language delay at 2.5 years: language disorder and developmental profiles

Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C

Neuropsychiatric Disease and Treatment 2018, 14:3267-3277

Published Date: 28 November 2018

Association of HLA alleles with autism

Sayad A, Akbari MT, Noroozi R, Omrani MD, Inoko H, Taheri M, Ghafouri-Fard S

Neuropsychiatric Disease and Treatment 2018, 14:3259-3265

Published Date: 27 November 2018

Dissociative states in borderline personality disorder and their relationships to psychotropic medication

Pec O, Bob P, Simek J, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3253-3257

Published Date: 23 November 2018

The association between depression, anxiety and substance use among Canadian post-secondary students

Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y

Neuropsychiatric Disease and Treatment 2018, 14:3241-3251

Published Date: 23 November 2018

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder

Cao P, Xing J, Cao Y, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, Song Z

Neuropsychiatric Disease and Treatment 2018, 14:3231-3240

Published Date: 26 November 2018

Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease

Zhou Y, Gu C, Li J, Zhu L, Huang G, Dai J, Huang H

Neuropsychiatric Disease and Treatment 2018, 14:3219-3229

Published Date: 22 November 2018

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Zuilhof Z, Norris S, Blondeau C, Tessier P, Blier P

Neuropsychiatric Disease and Treatment 2018, 14:3209-3218

Published Date: 22 November 2018

Brain structural networks and connectomes: the brain–obesity interface and its impact on mental health

Chen VCH, Liu YC, Chao SH, McIntyre RS, Cha DS, Lee Y, Weng JC

Neuropsychiatric Disease and Treatment 2018, 14:3199-3208

Published Date: 26 November 2018

The hospital anxiety and depression scale, in patients with multiple sclerosis

Pais-Ribeiro JL, Martins da Silva A, Vilhena E, Moreira I, Santos E, Mendonça D

Neuropsychiatric Disease and Treatment 2018, 14:3193-3197

Published Date: 22 November 2018

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study

Shiromaru-Sugimoto A, Murakami H, Futamura A, Honma M, Kuroda T, Kawamura M, Ono K

Neuropsychiatric Disease and Treatment 2018, 14:3185-3192

Published Date: 22 November 2018

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:3179-3184

Published Date: 22 November 2018

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

Jin X, Liu MY, Zhang DF, Gao H, Wei MJ

Neuropsychiatric Disease and Treatment 2018, 14:3159-3168

Published Date: 19 November 2018

Aberrant prefrontal–parietal–cerebellar circuits in alcohol dependence

Liu R, Liu BX, Ma M, Kong D, Li G, Yang J, Wu X, Zheng J, Dong Y

Neuropsychiatric Disease and Treatment 2018, 14:3143-3150

Published Date: 16 November 2018

Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats

Li C, Xu X, Zhang X, Cheng K, Guo Y, Jie J, Guo H, He Y, Zhou C, Gui S, Zhong X, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:3121-3132

Published Date: 15 November 2018

RIP1 and RIP3 mediate hemin-induced cell death in HT22 hippocampal neuronal cells

Su X, Wang H, Lin Y, Chen F

Neuropsychiatric Disease and Treatment 2018, 14:3111-3119

Published Date: 15 November 2018

Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis

Chang CH, Liu CY, Chen SJ, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:3091-3102

Published Date: 14 November 2018

Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis

Dalvand S, Ghanei Gheshlagh R, Kurdi A

Neuropsychiatric Disease and Treatment 2018, 14:3073-3080

Published Date: 13 November 2018

Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis

Maneeton N, Maneeton B, Putthisri S, Suttajit S, Likhitsathian S, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:3063-3072

Published Date: 12 November 2018

Economic analysis of acupuncture for migraine prophylaxis

Pokladnikova J, Maresova P, Dolejs J, Park AL, Wang B, Guan X, Musil F

Neuropsychiatric Disease and Treatment 2018, 14:3053-3061

Published Date: 12 November 2018

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice

Wang F, Feng J, Yang Y, Liu J, Liu M, Wang Z, Pei H, Wei Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:3037-3051

Published Date: 9 November 2018

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M

Neuropsychiatric Disease and Treatment 2018, 14:3033-3035

Published Date: 9 November 2018

Cognitive functioning in patients treated with electroconvulsive therapy

Kalisova L, Kubinova M, Michalec J, Albrecht J, Madlova K, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3025-3031

Published Date: 8 November 2018

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease

Giau VV, Senanarong V, Bagyinszky E, Limwongse C, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:3015-3023

Published Date: 8 November 2018

A prescription for “nature” – the potential of using virtual nature in therapeutics

White MP, Yeo NL, Vassiljev P, Lundstedt R, Wallergård M, Albin M, Lõhmus M

Neuropsychiatric Disease and Treatment 2018, 14:3001-3013

Published Date: 8 November 2018

Biomarkers in traumatic brain injury (TBI): a review

Dadas A, Washington J, Diaz-Arrastia R, Janigro D

Neuropsychiatric Disease and Treatment 2018, 14:2989-3000

Published Date: 8 November 2018

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia

Escamilla R, Camarena B, Saracco-Alvarez R, Fresán A, Hernández S, Aguilar-García A

Neuropsychiatric Disease and Treatment 2018, 14:2981-2987

Published Date: 5 November 2018

Parents’ impaired emotion recognition abilities are related to children’s autistic symptoms in autism spectrum disorder

Hu X, Yin L, Situ M, Guo K, Yang P, Zhang M, Huang Y

Neuropsychiatric Disease and Treatment 2018, 14:2973-2980

Published Date: 5 November 2018

Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients

Tu X, Qiu H, Lin S, He W, Huang G, Zhang X, Wu Y, He J

Neuropsychiatric Disease and Treatment 2018, 14:2947-2954

Published Date: 2 November 2018

Detection of cognitive impairment using a machine-learning algorithm

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2939-2945

Published Date: 1 November 2018

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report

Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K

Neuropsychiatric Disease and Treatment 2018, 14:2931-2937

Published Date: 1 November 2018

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study

Wu F, Zhang Y, Yang Y, Lu X, Fang Z, Huang J, Kong L, Chen J, Ning Y, Li X, Wu K

Neuropsychiatric Disease and Treatment 2018, 14:2889-2904

Published Date: 30 October 2018

Short duration of focal onset awareness and impaired awareness seizure are characteristic features of epilepsy in elderly patients

Fujimoto A, Okanishi T, Masuda Y, Sato K, Nishimura M, Baba S, Itamura S, Homma Y, Enoki H

Neuropsychiatric Disease and Treatment 2018, 14:2879-2887

Published Date: 30 October 2018

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:2861-2877

Published Date: 29 October 2018

Sexual dysfunction in cervical dystonia and blepharospasm

Marek M, Grobe-Einsler M, Bedarf JR, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2018, 14:2847-2852

Published Date: 26 October 2018

Neuroprogression: the hidden mechanism of depression

Labra Ruiz NA, Santamaría del Ángel D, Juárez Olguín H, Lindoro Silva M

Neuropsychiatric Disease and Treatment 2018, 14:2837-2845

Published Date: 30 October 2018

Neuromodulation in eating disorders and obesity: a promising way of treatment?

Jáuregui-Lobera I, Martínez-Quiñones JV

Neuropsychiatric Disease and Treatment 2018, 14:2817-2835

Published Date: 26 October 2018

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors

Černý M, Hodgins S, Kučíková R, Kážmér L, Lambertová A, Nawka A, Nawková L, Parzelka A, Raboch J, Bob P, Vevera J

Neuropsychiatric Disease and Treatment 2018, 14:2793-2805

Published Date: 23 October 2018

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC

Neuropsychiatric Disease and Treatment 2018, 14:2783-2791

Published Date: 23 October 2018

microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2

Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L

Neuropsychiatric Disease and Treatment 2018, 14:2773-2782

Published Date: 23 October 2018

Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study

Wang W, Li H, Peng D, Luo J, Xin H, Yu H, Yu J

Neuropsychiatric Disease and Treatment 2018, 14:2763-2772

Published Date: 17 October 2018

Depression, anxiety, and stress and their association with khat use: a cross-sectional study among Jazan University students, Saudi Arabia

Al Bahhawi T, Albasheer OB, Makeen AM, Arishi AM, Hakami OM, Maashi SM, Al-Khairat HK, Alganmy OM, Sahal YA, Sharif AA, Mahfouz MS

Neuropsychiatric Disease and Treatment 2018, 14:2755-2761

Published Date: 17 October 2018

Lithium treatment in bipolar adolescents: a follow-up naturalistic study

Masi G, Milone A, Scrinzi G, Mucci M, Viglione V, Bruni G, Berloffa S, Pisano S

Neuropsychiatric Disease and Treatment 2018, 14:2749-2753

Published Date: 17 October 2018

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Duncan Jr WC, Slonena EE, Hejazi NS, Brutsche N, Park LT, Henter ID, Ballard ED, Zarate Jr CA

Neuropsychiatric Disease and Treatment 2018, 14:2739-2748

Published Date: 16 October 2018

Neuronal connectivity in major depressive disorder: a systematic review

Helm K, Viol K, Weiger TM, Tass PA, Grefkes C, del Monte D, Schiepek G

Neuropsychiatric Disease and Treatment 2018, 14:2715-2737

Published Date: 17 October 2018

Minocycline as adjunct therapy for a male patient with deficit schizophrenia

Chen X, Xiong Z, Li Z, Yang Y, Zheng Z, Li Y, Xie Y, Li Z

Neuropsychiatric Disease and Treatment 2018, 14:2697-2701

Published Date: 12 October 2018

Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial

Qiu H, Ren W, Yang Y, Zhu X, Mao G, Mao S, Lin Y, Shen S, Li C, Shi H, Jiang S, He J, Zhao K, Fu Y, Hu X, Gu Y, Wang K, Guo X, He J

Neuropsychiatric Disease and Treatment 2018, 14:2665-2673

Published Date: 10 October 2018

Menstrual disorders and their determinants among women with epilepsy

Bosak M, Słowik A, Turaj W

Neuropsychiatric Disease and Treatment 2018, 14:2657-2664

Published Date: 10 October 2018

Neuropsychiatric disturbances in atypical parkinsonian disorders

Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:2643-2656

Published Date: 9 October 2018

Enduring effects of a five-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial

Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2633-2641

Published Date: 9 October 2018

Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing

Nazlidou E, Moraitou D, Natsopoulos D, Papaliagkas V, Masoura E, Papantoniou G

Neuropsychiatric Disease and Treatment 2018, 14:2617-2631

Published Date: 10 October 2018

Characteristics of brain functional and structural connectivity in alexithymic students

Fang Y, Li M, Mei M, Sun X, Han D

Neuropsychiatric Disease and Treatment 2018, 14:2609-2615

Published Date: 9 October 2018

Internalized stigma and its correlates among patients with severe mental illness

Szcześniak D, Kobyłko A, Wojciechowska I, Kłapciński M, Rymaszewska J

Neuropsychiatric Disease and Treatment 2018, 14:2599-2608

Published Date: 8 October 2018

Postseizure aphasia in Wernicke's encephalopathy: a case report and review of literature

Devaraj S, Muralles SA, Gill CE, Meresh E

Neuropsychiatric Disease and Treatment 2018, 14:2593-2598

Published Date: 8 October 2018

Upregulation of vitamin D-related genes in schizophrenic patients

Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A

Neuropsychiatric Disease and Treatment 2018, 14:2583-2591

Published Date: 9 October 2018

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N

Neuropsychiatric Disease and Treatment 2018, 14:2519-2530

Published Date: 1 October 2018

Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican population

Juárez-Rojop IE, Fortuny-Falconi CM, González-Castro TB, Tovilla-Zárate CA, Villar-Soto M, Rodríguez Sanchez E, Hernández-Díaz Y, López-Narvaez ML, Ble-Castillo JL, Pérez-Hernández N, Rodríguez-Pérez JM

Neuropsychiatric Disease and Treatment 2018, 14:2511-2518

Published Date: 4 October 2018

Construct validity and reliability of the Tachikawa Resilience Scale in the Japan Ground Self-Defense Force personnel

Saito T, Nagamine M, Shigemura J, Tanichi M, Toda H, Shimizu K, Yoshino A

Neuropsychiatric Disease and Treatment 2018, 14:2505-2510

Published Date: 2 October 2018

HPA-axis genes as potential risk variants for neurocognitive decline in trauma-exposed, HIV-positive females

Jacobs S, Moxley K, Womersley JS, Spies G, Hemmings SMJ, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:2497-2504

Published Date: 28 September 2018

The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis

González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Ramirez-Bello J, Pérez-Hernández N, Genis-Mendoza AD, Fresan A, Guzmán-Priego CG

Neuropsychiatric Disease and Treatment 2018, 14:2485-2496

Published Date: 28 September 2018

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Neuropsychiatric Disease and Treatment 2018, 14:2473-2484

Published Date: 26 September 2018

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder

Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:2461-2472

Published Date: 28 September 2018

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease

Choe YM, Byun MS, Lee JH, Sohn BK, Lee DY, Kim JW

Neuropsychiatric Disease and Treatment 2018, 14:2451-2460

Published Date: 24 September 2018

Automatic epilepsy detection using fractal dimensions segmentation and GP–SVM classification

Jirka J, Prauzek M, Krejcar O, Kuca K

Neuropsychiatric Disease and Treatment 2018, 14:2439-2449

Published Date: 21 September 2018

The microglial activation profile and associated factors after experimental spinal cord injury in rats

Zhou Y, Li N, Zhu L, Lin Y, Cheng H

Neuropsychiatric Disease and Treatment 2018, 14:2401-2413

Published Date: 20 September 2018

Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life

Chen CY, Wu CC, Huang YC, Hung CF, Wang LJ

Neuropsychiatric Disease and Treatment 2018, 14:2389-2399

Published Date: 19 September 2018

Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults

Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA

Neuropsychiatric Disease and Treatment 2018, 14:2379-2387

Published Date: 17 September 2018

PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad KA, Neupane SP

Neuropsychiatric Disease and Treatment 2018, 14:2367-2378

Published Date: 17 September 2018

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

Suda A, Hattori S, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Hirayasu Y

Neuropsychiatric Disease and Treatment 2018, 14:2361-2366

Published Date: 17 September 2018

Altered spontaneous brain activity patterns in strabismus with amblyopia patients using amplitude of low-frequency fluctuation: a resting-state fMRI study

Min YL, Su T, Shu YQ, Liu WF, Chen LL, Shi WQ, Jiang N, Zhu PW, Yuan Q, Xu XW, Ye L, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:2351-2359

Published Date: 17 September 2018

A randomized controlled trial of mindfulness-based Tai Chi Chuan for subthreshold depression adolescents

Zhang JY, Qin SD, Zhou YQ, Meng LN, Su H, Zhao S

Neuropsychiatric Disease and Treatment 2018, 14:2313-2321

Published Date: 10 September 2018

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients

Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J

Neuropsychiatric Disease and Treatment 2018, 14:2307-2312

Published Date: 6 September 2018

Children with autism spectrum disorders and selective mutism [Corrigendum]

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:2305-2306

Published Date: 6 September 2018

Prescreening clinical trial volunteers using an online personality questionnaire

Patrick F, Young AH, Williams SCR, Perkins AM

Neuropsychiatric Disease and Treatment 2018, 14:2297-2303

Published Date: 5 September 2018

Trajectories of callous–unemotional traits from childhood to adolescence in referred youth with a disruptive behavior disorder who received intensive multimodal therapy in childhood

Masi G, Pisano S, Brovedani P, Maccaferri G, Manfredi A, Milone A, Nocentini A, Polidori L, Ruglioni L, Muratori P

Neuropsychiatric Disease and Treatment 2018, 14:2287-2296

Published Date: 5 September 2018

Do eyes with and without optic neuritis in multiple sclerosis age equally?

Lizrova Preiningerova J, Grishko A, Sobisek L, Andelova M, Benova B, Kucerova K, Havrdova EK

Neuropsychiatric Disease and Treatment 2018, 14:2281-2285

Published Date: 5 September 2018

Victimization and posttraumatic stress disorder in homeless women with mental illness are associated with depression, suicide, and quality of life

Tinland A, Boyer L, Loubière S, Greacen T, Girard V, Boucekine M, Fond G, Auquier P

Neuropsychiatric Disease and Treatment 2018, 14:2269-2279

Published Date: 4 September 2018

Vulnerability or resilience of motopsin knockout mice to maternal separation stress depending on adulthood behaviors

Hidaka C, Kashio T, Uchigaki D, Mitsui S

Neuropsychiatric Disease and Treatment 2018, 14:2255-2268

Published Date: 4 September 2018

Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis

Gao F, Chen C, Lyu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2018, 14:2233-2239

Published Date: 3 September 2018

Platelet membrane receptor P2Y12 H1/H2 polymorphisms is highly associated with cerebral infarction: a case-control study

Lu SJ, Zhou XS, Zheng Q, Chen HL, Geng YL

Neuropsychiatric Disease and Treatment 2018, 14:2225-2231

Published Date: 30 August 2018

Relationship between social and cognitive functions in people with schizophrenia

Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:2215-2224

Published Date: 30 August 2018

Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome

Yılmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A

Neuropsychiatric Disease and Treatment 2018, 14:2207-2214

Published Date: 29 August 2018

Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway

Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y

Neuropsychiatric Disease and Treatment 2018, 14:2191-2206

Published Date: 28 August 2018

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Zhi P, Wang Y, Quan W, Su Y, Zhang H

Neuropsychiatric Disease and Treatment 2018, 14:2175-2179

Published Date: 27 August 2018

EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios

Kamaradova D, Brunovsky M, Prasko J, Horacek J, Hajda M, Grambal A, Latalova K

Neuropsychiatric Disease and Treatment 2018, 14:2165-2174

Published Date: 27 August 2018

Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report

Takagaki K, Okamoto Y, Jinnin R, Yokoyama S, Yoshino A, Kagawa F, Okamoto Y, Miyake Y, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2159-2164

Published Date: 27 August 2018

ESSENCE-Q: Slavic language versions for developmental screening in young children

Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, Petrov P, Hadžagić Ćatibušić F, Deljković A, Brkic Cvetkovic S, Vrljičak Davidovic N, Kuzmanić Šamija R, Đorić A, Gillberg C

Neuropsychiatric Disease and Treatment 2018, 14:2141-2148

Published Date: 23 August 2018

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease

Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH

Neuropsychiatric Disease and Treatment 2018, 14:2133-2140

Published Date: 21 August 2018

Construction of an Arabic computerized battery for cognitive rehabilitation of children with specific learning disabilities

Farghaly WMA, Ahmed MA, El-Tallawy HN, Elmestikawy TAH, Badry R, Farghaly MS, Omar MS, Hussein ASR, Salamah M, Mohammed AT

Neuropsychiatric Disease and Treatment 2018, 14:2123-2131

Published Date: 21 August 2018

Investigation of chromosome Y loss in men with schizophrenia

Hirata T, Hishimoto A, Otsuka I, Okazaki S, Boku S, Kimura A, Horai T, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:2115-2122

Published Date: 20 August 2018

The interactive effects of ketamine and ethanol on dopamine expression in the ventral tegmental area of rats

Zhang ZB, Xu TY, You DY, Yi S, Liu Q, Li HJ, Gu JY

Neuropsychiatric Disease and Treatment 2018, 14:2105-2114

Published Date: 20 August 2018

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T

Neuropsychiatric Disease and Treatment 2018, 14:2099-2104

Published Date: 17 August 2018

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C

Neuropsychiatric Disease and Treatment 2018, 14:2087-2097

Published Date: 14 August 2018

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases

Bagyinszky E, Giau VV, Youn YC, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2067-2085

Published Date: 14 August 2018

Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years

Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A

Neuropsychiatric Disease and Treatment 2018, 14:2057-2065

Published Date: 13 August 2018

Schizophrenia and risk of dementia: a meta-analysis study

Cai LS, Huang JW

Neuropsychiatric Disease and Treatment 2018, 14:2047-2055

Published Date: 13 August 2018

Social communication disorder: a narrative review on current insights

Topal Z, Demir Samurcu N, Taskiran S, Tufan AE, Semerci B

Neuropsychiatric Disease and Treatment 2018, 14:2039-2046

Published Date: 13 August 2018

Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Asadi S

Neuropsychiatric Disease and Treatment 2018, 14:2027-2038

Published Date: 10 August 2018

Associations between stress and depression symptom profiles vary according to serotonin transporter polymorphism in rural Australians

Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL

Neuropsychiatric Disease and Treatment 2018, 14:2007-2016

Published Date: 10 August 2018

Assessment of relevant factors with respect to psychosocial properties in potential living donor candidates before liver transplantation

Wu MK, Hsu LW, Huang KT, Lin CC, Wang CC, Lin TL, Li WF, Goto S, Chen CL, Chen CC

Neuropsychiatric Disease and Treatment 2018, 14:1999-2005

Published Date: 8 August 2018

Resting-state functional changes in the precuneus within first-episode drug-naive patients with MDD

Li G, Rossbach K, Zhang A, Liu P, Zhang K

Neuropsychiatric Disease and Treatment 2018, 14:1991-1998

Published Date: 7 August 2018

Evaluation of BPPV with vertebral artery values

Yazıcı A, İnanç Y

Neuropsychiatric Disease and Treatment 2018, 14:1975-1979

Published Date: 6 August 2018

Impact of aerobic exercise on muscle mass in patients with major depressive disorder: a randomized controlled trial

Kerling A, Hartung D, Stubbs B, Kück M, Tegtbur U, Grams L, Weber-Spickschen TS, Kahl KG

Neuropsychiatric Disease and Treatment 2018, 14:1969-1974

Published Date: 6 August 2018

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review

Maneeton B, Maneeton N, Likhitsathian S, Woottiluk P, Wiriyacosol P, Boonyanaruthee V, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:1953-1961

Published Date: 2 August 2018

Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease

Dong J, Ma X, Lin W, Liu M, Fu S, Yang L, Jiang G

Neuropsychiatric Disease and Treatment 2018, 14:1929-1939

Published Date: 2 August 2018

Tinnitus distress is associated with enhanced resting-state functional connectivity within the default mode network

Chen YC, Chen H, Bo F, Xu JJ, Deng Y, Lv H, Cai Y, Xia W, Yin X, Gu JP, Lu GM

Neuropsychiatric Disease and Treatment 2018, 14:1919-1927

Published Date: 1 August 2018

Cognitive and metacognitive factors among alcohol-dependent patients during a residential rehabilitation program: a pilot study

Torselli E, Ottonello M, Franceschina E, Palagi E, Bertolotti G, Fiabane E

Neuropsychiatric Disease and Treatment 2018, 14:1907-1917

Published Date: 31 July 2018

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease

Kose Ozlece H, Findik Guvendi G, Huseyinoglu N, Ehi Y, Kivrak Y

Neuropsychiatric Disease and Treatment 2018, 14:1901-1906

Published Date: 31 July 2018

Profiling undergraduate students from a Romanian medical university

Romosan RS, Dehelean L, Enatescu VR, Bredicean AC, Papava I, Giurgi-Oncu C, Romosan AM

Neuropsychiatric Disease and Treatment 2018, 14:1891-1899

Published Date: 24 July 2018

Frontal lobe metabolic alterations in autism spectrum disorder: a 1H-magnetic resonance spectroscopy study

Margari L, De Giacomo A, Craig F, Palumbi R, Peschechera A, Margari M, Picardi F, Caldarola M, Maghenzani MA, Dicuonzo F

Neuropsychiatric Disease and Treatment 2018, 14:1871-1876

Published Date: 20 July 2018

Cortical gyrification in schizophrenia: current perspectives

Matsuda Y, Ohi K

Neuropsychiatric Disease and Treatment 2018, 14:1861-1869

Published Date: 19 July 2018

Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia

Guzel D, Yazici AB, Mutu Pek T, Doganay S, Saykan Simsek AB, Saglam K, Turan C, Yazici E

Neuropsychiatric Disease and Treatment 2018, 14:1855-1860

Published Date: 16 July 2018

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan

Montgomery W, Goren A, Kahle-Wrobleski K, Nakamura T, Ueda K

Neuropsychiatric Disease and Treatment 2018, 14:1843-1854

Published Date: 16 July 2018

Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis

Shih JH, Zeng BY, Lin PY, Chen TY, Chen YW, Wu CK, Tseng PT, Wu MK

Neuropsychiatric Disease and Treatment 2018, 14:1831-1842

Published Date: 18 July 2018

A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression

Bangratz M, Ait Abdellah S, Berlin A, Blondeau C, Guilbot A, Dubourdeaux M, Lemoine P

Neuropsychiatric Disease and Treatment 2018, 14:1821-1829

Published Date: 13 July 2018

Risperidone for children and adolescents with autism spectrum disorder: a systematic review

Maneeton N, Maneeton B, Putthisri S, Woottiluk P, Narkpongphun A, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:1811-1820

Published Date: 11 July 2018

Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus

Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:1803-1809

Published Date: 10 July 2018

Gender differences in the protective effects of green tea against amnestic mild cognitive impairment in the elderly Han population

Xu H, Wang Y, Yuan Y, Zhang X, Zuo XY, Cui L, Liu Y, Chen W, Su N, Wang H, Yan F, Li X, Wang T, Xiao S

Neuropsychiatric Disease and Treatment 2018, 14:1795-1801

Published Date: 10 July 2018

Relation of high neuroticism with increased methylation of the BDNF gene

Shirata T, Suzuki A, Matsumoto Y, Takahashi N, Noto K, Goto K, Otani K

Neuropsychiatric Disease and Treatment 2018, 14:1787-1793

Published Date: 9 July 2018

Preschool-onset obsessive-compulsive disorder with complete remission

Miyawaki D, Goto A, Iwakura Y, Hirai K, Miki Y, Asada N, Terakawa H, Inoue K

Neuropsychiatric Disease and Treatment 2018, 14:1747-1753

Published Date: 3 July 2018

Transcranial magnetic stimulation in the treatment of obsessive–compulsive disorder: current perspectives

Lusicic A, Schruers KRJ, Pallanti S, Castle DJ

Neuropsychiatric Disease and Treatment 2018, 14:1721-1736

Published Date: 29 June 2018

Frequency of inborn errors of metabolism screening for children with unexplained acute encephalopathy at an emergency department

Abdel Maksoud M, ELsayed SM, Shatla RH, Imam AA, Elsayed RM, Mosabah AA, Sherif AM

Neuropsychiatric Disease and Treatment 2018, 14:1715-1720

Published Date: 29 June 2018

The effect of depression on fracture healing and osteoblast differentiation in rats

Nie C, Wang Z, Liu X

Neuropsychiatric Disease and Treatment 2018, 14:1705-1713

Published Date: 29 June 2018

Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability

Schmidt SL, Santos da Silva M, Schmidt JJ, Carvalho ALN, Vasconcelos CCF, Paes RA, Boechat YEM, Neder R, Alvarenga RP

Neuropsychiatric Disease and Treatment 2018, 14:1665-1670

Published Date: 22 June 2018

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia

Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H

Neuropsychiatric Disease and Treatment 2018, 14:1657-1663

Published Date: 22 June 2018

The detection of white matter alterations in obsessive–compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA)

Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J

Neuropsychiatric Disease and Treatment 2018, 14:1635-1643

Published Date: 19 June 2018

The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review

He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW

Neuropsychiatric Disease and Treatment 2018, 14:1627-1633

Published Date: 18 June 2018

Vibration therapy in patients with cerebral palsy: a systematic review

Ritzmann R, Stark C, Krause A

Neuropsychiatric Disease and Treatment 2018, 14:1607-1625

Published Date: 18 June 2018

Mindfulness-based cognitive therapy in patients with depression: current perspectives

MacKenzie MB, Abbott KA, Kocovski NL

Neuropsychiatric Disease and Treatment 2018, 14:1599-1605

Published Date: 18 June 2018

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study

Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:1585-1597

Published Date: 15 June 2018

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2018, 14:1535-1543

Published Date: 14 June 2018

Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular

Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A

Neuropsychiatric Disease and Treatment 2018, 14:1521-1526

Published Date: 13 June 2018

The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis

Majdinasab N, Namjoyan F, Taghizadeh M, Saki H

Neuropsychiatric Disease and Treatment 2018, 14:1505-1512

Published Date: 12 June 2018

Electroencephalogram alpha asymmetry in patients with depressive disorders: current perspectives

Kaiser AK, Gnjezda MT, Knasmüller S, Aichhorn W

Neuropsychiatric Disease and Treatment 2018, 14:1493-1504

Published Date: 11 June 2018

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU

Neuropsychiatric Disease and Treatment 2018, 14:1475-1492

Published Date: 8 June 2018

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1

Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M

Neuropsychiatric Disease and Treatment 2018, 14:1463-1474

Published Date: 8 June 2018

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics

Gui SW, Liu YY, Zhong XG, Liu XY, Zheng P, Pu JC, Zhou J, Chen JJ, Zhao LB, Liu LX, Xu GW, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:1451-1461

Published Date: 6 June 2018

A review of ketamine’s role in ECT and non-ECT settings

Jankauskas V, Necyk C, Chue J, Chue P

Neuropsychiatric Disease and Treatment 2018, 14:1437-1450

Published Date: 6 June 2018

Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report

Pan F, Li S, Li H, Xu Y, Huang M

Neuropsychiatric Disease and Treatment 2018, 14:1433-1435

Published Date: 5 June 2018

Investigation on dysfunctional beliefs and attitudes about sleep in Chinese college students

Jin LR, Zhou J, Peng H, Ding SS, Yuan H

Neuropsychiatric Disease and Treatment 2018, 14:1425-1432

Published Date: 1 June 2018

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Holubova M, Kantor K, Kolek A, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2018, 14:1415-1424

Published Date: 1 June 2018

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report

Duan JF, Lao CM, Chen JK, Pan F, Zhang CL, Xu WJ, Zhou WH, Hu JB, Shang DS, Huang ML, Xu Y

Neuropsychiatric Disease and Treatment 2018, 14:1395-1398

Published Date: 30 May 2018

Mothers and fathers of children with epilepsy: gender differences in post-traumatic stress symptoms and correlations with mood spectrum symptoms

Carmassi C, Corsi M, Bertelloni CA, Carpita B, Gesi C, Pedrinelli V, Massimetti G, Peroni DG, Bonuccelli A, Orsini A, Dell’Osso L

Neuropsychiatric Disease and Treatment 2018, 14:1371-1379

Published Date: 25 May 2018

Incidence of venous thromboembolism in psychiatric inpatients: a chart review

Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1363-1370

Published Date: 23 May 2018

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM

Neuropsychiatric Disease and Treatment 2018, 14:1339-1350

Published Date: 22 May 2018

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:1319-1327

Published Date: 22 May 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1307-1308

Published Date: 22 May 2018

Differences in psychopathology and behavioral characteristics of patients affected by conversion motor disorder and organic dystonia

Pastore A, Pierri G, Fabio G, Ferramosca S, Gigante A, Superbo M, Pellicciari R, Margari F

Neuropsychiatric Disease and Treatment 2018, 14:1287-1295

Published Date: 18 May 2018

Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation

Omori Y, Kanbayashi T, Sagawa Y, Imanishi A, Tsutsui K, Takahashi Y, Takeshima M, Takaki M, Nishino S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1281-1286

Published Date: 18 May 2018

Harm avoidance and depression, anxiety, insomnia, and migraine in fifth-year medical students in Taiwan

Chen CY, Yu NW, Huang TH, Wang WS, Fang JT

Neuropsychiatric Disease and Treatment 2018, 14:1273-1280

Published Date: 16 May 2018

Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis

Huang M, Zhou F, Wu L, Wang B, Wan H, Li F, Zeng X, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1241-1252

Published Date: 14 May 2018

Disrupted interhemispheric functional connectivity in chronic insomnia disorder: a resting-state fMRI study

Zhou F, Zhao Y, Huang M, Zeng X, Wang B, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1229-1240

Published Date: 14 May 2018

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

Musil F, Pokladnikova J, Pavelek Z, Wang B, Guan X, Valis M

Neuropsychiatric Disease and Treatment 2018, 14:1221-1228

Published Date: 10 May 2018

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

Masopust J, Protopopová D, Vališ M, Pavelek Z, Klímová B

Neuropsychiatric Disease and Treatment 2018, 14:1211-1220

Published Date: 9 May 2018

Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies

Wang HY, Zhang XX, Si CP, Xu Y, Liu Q, Bian HT, Zhang BW, Li XL, Yan ZR

Neuropsychiatric Disease and Treatment 2018, 14:1183-1198

Published Date: 9 May 2018

The impact of total sleep deprivation upon cognitive functioning in firefighters

Kujawski S, Słomko J, Tafil-Klawe M, Zawadka-Kunikowska M, Szrajda J, Newton JL, Zalewski P, Klawe JJ

Neuropsychiatric Disease and Treatment 2018, 14:1171-1181

Published Date: 8 May 2018

Children with autism spectrum disorders and selective mutism

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:1163-1169

Published Date: 7 May 2018

The effects of Maras powder use on patients with migraine

İnanç Y, Orhan FÖ, İnanç Y

Neuropsychiatric Disease and Treatment 2018, 14:1143-1148

Published Date: 7 May 2018

Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele

Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E

Neuropsychiatric Disease and Treatment 2018, 14:1139-1142

Published Date: 4 May 2018

Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion

Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G

Neuropsychiatric Disease and Treatment 2018, 14:1125-1138

Published Date: 27 April 2018

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC

Neuropsychiatric Disease and Treatment 2018, 14:1101-1106

Published Date: 30 April 2018

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

Frau J, Coghe G, Lorefice L, Fenu G, Cocco E

Neuropsychiatric Disease and Treatment 2018, 14:1093-1099

Published Date: 23 April 2018

Comparison of changes in oxygenated hemoglobin during the tree-drawing task between patients with schizophrenia and healthy controls

Nakano S, Shoji Y, Morita K, Igimi H, Sato M, Ishii Y, Kondo A, Uchimura N

Neuropsychiatric Disease and Treatment 2018, 14:1071-1082

Published Date: 20 April 2018

Aberrant brain functional connectome in patients with obstructive sleep apnea

Chen L, Fan X, Li H, Ye C, Yu H, Xin H, Gong H, Peng D, Yan L

Neuropsychiatric Disease and Treatment 2018, 14:1059-1070

Published Date: 18 April 2018

Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report

Mędrala T, Pycińska A, Pyciński B, Merk W, Kucia K

Neuropsychiatric Disease and Treatment 2018, 14:1055-1058

Published Date: 17 April 2018

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis

Xu Y, Li X, Zhuang S, Guo S, Xiang J, Wang L, Zhou L, Wu B

Neuropsychiatric Disease and Treatment 2018, 14:1035-1046

Published Date: 16 April 2018

Does higher severity really correlate with a worse quality of life in obsessive–compulsive disorder? A meta-regression

Pozza A, Lochner C, Ferretti F, Cuomo A, Coluccia A

Neuropsychiatric Disease and Treatment 2018, 14:1013-1023

Published Date: 16 April 2018

Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex

Hu Q, Shen P, Bai S, Dong M, Liang Z, Chen Z, Wang W, Wang H, Gui S, Li P, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:999-1011

Published Date: 13 April 2018

The functional and structural characteristics of the emotion network in alexithymia

Han D, Li M, Mei MJ, Sun XF

Neuropsychiatric Disease and Treatment 2018, 14:991-998

Published Date: 12 April 2018

The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study

Sampogna G, Luciano M, Del Vecchio V, Malangone C, De Rosa C, Giallonardo V, Borriello G, Pocai B, Savorani M, Steardo L Jr, Lampis D, Veltro F, Bartoli F, Bardicchia F, Moroni AM, Ciampini G, Orlandi E, Ferrari S, Biondi S, Iapichino S, Pompili E, Piselli M, Tortorella A, Carrà G, Fiorillo A

Neuropsychiatric Disease and Treatment 2018, 14:977-989

Published Date: 11 April 2018

Insomnia in hospitalized psychiatric patients: prevalence and associated factors

Talih F, Ajaltouni J, Ghandour H, Abu-Mohammad AS, Kobeissy F

Neuropsychiatric Disease and Treatment 2018, 14:969-975

Published Date: 10 April 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study [Corrigendum]

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:967-968

Published Date: 10 April 2018

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study

Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T

Neuropsychiatric Disease and Treatment 2018, 14:955-966

Published Date: 6 April 2018

Elevated peripheral blood glutamate levels in major depressive disorder

Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:945-953

Published Date: 6 April 2018

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats

Kanada Y, Katayama A, Ikemoto H, Takahashi K, Tsukada M, Nakamura A, Ishino S, Hisamitsu T, Sunagawa M

Neuropsychiatric Disease and Treatment 2018, 14:937-944

Published Date: 6 April 2018

Investigation of variants in estrogen receptor genes and perinatal depression

Tan EC, Lim HW, Chua TE, Tan HS, Lee TMY, Chen HY

Neuropsychiatric Disease and Treatment 2018, 14:919-925

Published Date: 29 March 2018

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases

Dell'Osso B, Oldani L, Grancini B, Dario A, Altamura AC

Neuropsychiatric Disease and Treatment 2018, 14:915-918

Published Date: 29 March 2018

Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation

Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM

Neuropsychiatric Disease and Treatment 2018, 14:903-913

Published Date: 29 March 2018

Serum levels of GPER -1 in euthymic bipolar patients

Orhan FÖ, Kurutaş EB, Doğaner A, Türker E, Taner Özcü SŞ, Güngör M, Çakmak S

Neuropsychiatric Disease and Treatment 2018, 14:855-862

Published Date: 26 March 2018

Aberrant regional brain activities in alcohol dependence: a functional magnetic resonance imaging study

Tu XZ, Wang JJ, Liu XM, Zheng JY

Neuropsychiatric Disease and Treatment 2018, 14:847-853

Published Date: 22 March 2018

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease

Hauser RA, Ellenbogen A, Khanna S, Gupta S, Modi NB

Neuropsychiatric Disease and Treatment 2018, 14:839-845

Published Date: 22 March 2018

Continuous performance task in ADHD: Is reaction time variability a key measure?

Levy F, Pipingas A, Harris EV, Farrow M, Silberstein RB

Neuropsychiatric Disease and Treatment 2018, 14:781-786

Published Date: 15 March 2018

Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study

Baran G, Ozdemir Gultekin T, Baran O, Deniz C, Katar S, Babacan Yildiz G, Asil T

Neuropsychiatric Disease and Treatment 2018, 14:757-766

Published Date: 13 March 2018

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study

Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A

Neuropsychiatric Disease and Treatment 2018, 14:749-755

Published Date: 13 March 2018

Novel treatment options in depression and psychosis

Ceskova E, Silhan P

Neuropsychiatric Disease and Treatment 2018, 14:741-747

Published Date: 13 March 2018

Secondary central nervous system lymphoma: spectrum of morphological MRI appearances

Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J

Neuropsychiatric Disease and Treatment 2018, 14:733-740

Published Date: 12 March 2018

Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan

Chen CY, Tang TC, Chen TT, Bai YM, Tsai HH, Chen HL, Huang CJ, Chen CK, Chen CC, Hsiao MC, Liu CY, Yeh HS, Chiu NY, Hsiao CC, Chen CS, Su TP

Neuropsychiatric Disease and Treatment 2018, 14:725-732

Published Date: 8 March 2018

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response

Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:715-723

Published Date: 8 March 2018

Aggressiveness, violence, homicidality, homicide, and Lyme disease

Bransfield RC

Neuropsychiatric Disease and Treatment 2018, 14:693-713

Published Date: 9 March 2018

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment

Tompsett T, Masters K, Donyai P

Neuropsychiatric Disease and Treatment 2018, 14:681-691

Published Date: 2 March 2018

Evaluating psychiatric readmissions in the emergency department of a large public hospital

Morris DW, Ghose S, Williams E, Brown K, Khan F

Neuropsychiatric Disease and Treatment 2018, 14:671-679

Published Date: 1 March 2018

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients

Horai T, Hishimoto A, Otsuka I, So T, Mouri K, Shimmyo N, Boku S, Okishio N, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:663-669

Published Date: 28 February 2018

Sex differences in gut microbiota in patients with major depressive disorder

Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:647-655

Published Date: 26 February 2018

Childhood trauma and dissociation among women with genito-pelvic pain/penetration disorder

Özen B, Özdemir YO, Beştepe EE

Neuropsychiatric Disease and Treatment 2018, 14:641-646

Published Date: 23 February 2018

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny A, Girgis M, Nada MA, Hassan A, Mourad HS, Hegazy MI, Abdelalim A, Kishk NA, Abokrysha NT, Genedy SA, Essawy EA, Shehata HS

Neuropsychiatric Disease and Treatment 2018, 14:631-640

Published Date: 23 February 2018

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL

Neuropsychiatric Disease and Treatment 2018, 14:611-621

Published Date: 22 February 2018

IQ discrepancy differentiates levels of fine motor skills and their relationship in children with autism spectrum disorders

Yu TY, Chou W, Chow JC, Lin CH, Tung LC, Chen KL

Neuropsychiatric Disease and Treatment 2018, 14:597-605

Published Date: 20 February 2018

Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder

Sahin N, Altun H, Kurutas EB, Balkan D

Neuropsychiatric Disease and Treatment 2018, 14:581-585

Published Date: 19 February 2018

Drug–drug interactions involving antidepressants: focus on desvenlafaxine

Low Y, Setia S, Lima G

Neuropsychiatric Disease and Treatment 2018, 14:567-580

Published Date: 19 February 2018

Human factors evaluation of a novel digital medicine system in psychiatry

Peters-Strickland T, Hatch A, Adenwala A, Atkinson K, Bartfeld B

Neuropsychiatric Disease and Treatment 2018, 14:553-565

Published Date: 16 February 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:517-524

Published Date: 14 February 2018

Corpus callosum infarction with cognitive dysfunction: two case reports and literature review

Zhang J, Tang Y, Sun Y, Xu Y, Pang L, Li J, Wu T, He M

Neuropsychiatric Disease and Treatment 2018, 14:511-515

Published Date: 13 February 2018

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:505-510

Published Date: 12 February 2018

Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation

Fan J, Fong T, Chen X, Chen C, Luo P, Xie H

Neuropsychiatric Disease and Treatment 2018, 14:495-504

Published Date: 9 February 2018

The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis

Kessels E, Husson O, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2018, 14:479-494

Published Date: 9 February 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:451-457

Published Date: 8 February 2018

Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study

Chang CH, Chen SJ, Liu CY, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:443-450

Published Date: 7 February 2018

The differences between patients with panic disorder and healthy controls in psychophysiological stress profile

Kotianova A, Kotian M, Slepecky M, Chupacova M, Prasko J, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2018, 14:435-441

Published Date: 7 February 2018

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease

Berardelli I, Bloise MC, Bologna M, Conte A, Pompili M, Lamis DA, Pasquini M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:399-405

Published Date: 26 January 2018

Color preferences in participants with high or low hypnotic susceptibility

Yu E, Zhu J, Tan Y, Liao Z, Qiu Y, Zhang B, Wang C, Wang W

Neuropsychiatric Disease and Treatment 2018, 14:393-398

Published Date: 30 January 2018

Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis

Ociskova M, Prasko J, Vrbova K, Kasalova P, Holubova M, Grambal A, Machu K

Neuropsychiatric Disease and Treatment 2018, 14:383-392

Published Date: 26 January 2018

Adjustment disorder: current perspectives

Zelviene P, Kazlauskas E

Neuropsychiatric Disease and Treatment 2018, 14:375-381

Published Date: 25 January 2018

Oxidative/antioxidative status, lymphocyte DNA damage, and urotensin-2 receptor level in patients with migraine attacks

Yigit M, Sogut O, Tataroglu Ö, Yamanoglu A, Yigit E, Guler EM, Ozer OF, Kocyigit A

Neuropsychiatric Disease and Treatment 2018, 14:367-374

Published Date: 24 January 2018

The impact of age of onset on amygdala intrinsic connectivity in major depression

Clark DL, Konduru N, Kemp A, Bray S, Brown EC, Goodyear B, Ramasubbu R

Neuropsychiatric Disease and Treatment 2018, 14:343-352

Published Date: 22 January 2018

Reflex epilepsy: triggers and management strategies

Okudan ZV, Özkara Ç

Neuropsychiatric Disease and Treatment 2018, 14:327-337

Published Date: 18 January 2018

Systematic review of catatonia treatment

Pelzer ACM, van der Heijden FMMA, den Boer E

Neuropsychiatric Disease and Treatment 2018, 14:317-326

Published Date: 17 January 2018

“Low road” to rehabilitation: a perspective on subliminal sensory neuroprosthetics

Ghai S, Ghai I, Effenberg AO

Neuropsychiatric Disease and Treatment 2018, 14:301-307

Published Date: 17 January 2018

ADHD and lifestyle habits in Czech adults, a national sample

Weissenberger S, Ptacek R, Vnukova M, Raboch J, Klicperova-Baker M, Domkarova L, Goetz M

Neuropsychiatric Disease and Treatment 2018, 14:293-299

Published Date: 15 January 2018

Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

Kasemsap N, Vorasoot N, Kongbunkiat K, Peansukwech U, Tiamkao S, Sawanyawisuth K

Neuropsychiatric Disease and Treatment 2018, 14:259-264

Published Date: 9 January 2018

Altered intrinsic brain activities in patients with acute eye pain using amplitude of low-frequency fluctuation: a resting-state fMRI study

Pan Z, Li H, Bao J, Jiang N, Yuan Q, Freeberg S, Zhu P, Ye L, Ma M, Huang X, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:251-257

Published Date: 9 January 2018

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:239-249

Published Date: 9 January 2018

Anxiety and depression in paradoxical insomnia: a case–control study

Liao J, Zhu S, Li X

Neuropsychiatric Disease and Treatment 2018, 14:231-238

Published Date: 8 January 2018

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Maciel A, Cullors A, Lukowiak AA, Garces J

Neuropsychiatric Disease and Treatment 2018, 14:225-230

Published Date: 8 January 2018

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

Introna A, D'Errico E, Modugno B, Scarafino A, Fraddosio A, Distaso E, Tempesta I, Mastronardi A, Simone IL

Neuropsychiatric Disease and Treatment 2018, 14:193-203

Published Date: 4 January 2018

Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai

Huang J, Chiovenda A, Shao Y, Ma H, Li H, Good MJDV

Neuropsychiatric Disease and Treatment 2018, 14:185-191

Published Date: 4 January 2018

Diagnostic challenges in multiple system atrophy

Obelieniene D, Bauzaite S, Kulakiene I, Keleras E, Eitmonaite I, Rastenyte D

Neuropsychiatric Disease and Treatment 2018, 14:179-184

Published Date: 4 January 2018

The current status of culturally adapted mental health interventions: a practice-focused review of meta-analyses

Rathod S, Gega L, Degnan A, Pikard J, Khan T, Husain N, Munshi T, Naeem F

Neuropsychiatric Disease and Treatment 2018, 14:165-178

Published Date: 4 January 2018

A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia

Xu F, Wu X, Zhang J, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2018, 14:153-164

Published Date: 3 January 2018

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M

Neuropsychiatric Disease and Treatment 2018, 14:103-115

Published Date: 29 December 2017

Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression

Gao J, Xu W, Han K, Zhu L, Gao L, Shang XL

Neuropsychiatric Disease and Treatment 2018, 14:83-93

Published Date: 27 December 2017

Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study

Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M

Neuropsychiatric Disease and Treatment 2018, 14:73-82

Published Date: 22 December 2017

An acute bout of housework activities has beneficial effects on executive function

Tsuchiya K, Mitsui S, Fukuyama R, Yamaya N, Fujita T, Shimoda K, Tozato F

Neuropsychiatric Disease and Treatment 2018, 14:61-72

Published Date: 22 December 2017

Plasma complement component 4 increases in patients with major depressive disorder

Wei J, Liu Y, Zhao L, Yang X, Ni P, Wang Y, Li T, Ma X

Neuropsychiatric Disease and Treatment 2018, 14:37-41

Published Date: 20 December 2017

Migraine in young females with irritable bowel syndrome: still a challenge

Georgescu D, Reisz D, Gurban CV, Georgescu LA, Ionita I, Ancusa OE, Lighezan D

Neuropsychiatric Disease and Treatment 2018, 14:21-28

Published Date: 20 December 2017

Brain functional integration: an epidemiologic study on stress-producing dissociative phenomena

Sperandeo R, Monda V, Messina G, Carotenuto M, Maldonato NM, Moretto E, Leone E, De Luca V, Monda M, Messina A

Neuropsychiatric Disease and Treatment 2018, 14:11-19

Published Date: 19 December 2017